Abstract
Traditional reinforcement learning (RL) in clinical settings often struggles with the ethical and practical constraints of exploration. This paper introduces Dead-end Discovery (DeD), a framework that shifts the focus from finding optimal treatments to identifying "dead-ends"—states where negative outcomes become inevitable regardless of future actions. By utilizing dual Markov Decision Processes (D-Network for death probability and R-Network for recovery probability), the authors define "treatment security" to flag high-risk clinical decisions. Evaluated on the MIMIC-III sepsis cohort, the model identifies unavoidable trajectories 4 to 8 hours before traditional clinical markers, revealing a significant gap between administered treatments and those deemed most secure.
Introduction
Reinforcement Learning (RL) has long promised to revolutionize healthcare by recommending optimal treatments. However, standard RL requires "exploration"—trying different actions to see what happens. In an Intensive Care Unit (ICU), exploring sub-optimal treatments is unethical and dangerous. Furthermore, most medical data is "offline" and non-exploratory; it only shows what doctors actually did. When RL models try to find an "optimal" policy from this limited data, they often overfit to noise or suggest dangerous actions because they haven't seen the negative consequences of those actions. This paper shifts the goal: instead of finding the best treatment, can we use data to identify which treatments are guaranteed to lead to inescapable negative outcomes?
Methods
The authors introduce Dead-end Discovery (DeD), a framework built on three key components:
- Dual MDPs: The problem is framed using two separate Markov Decision Processes. The D-Network (Discovery) learns to estimate the minimum probability of a negative outcome (death), while the R-Network (Reachability) estimates the maximum probability of a positive outcome (recovery).
- Treatment Security: A "secure" treatment is mathematically defined as one that avoids states where the probability of death becomes 1.0 (a dead-end).
- Neural Architecture: An "Approximate Information State" (AIS) model creates informative embeddings of a patient's condition over time from messy ICU data. D and R Networks are then trained using Double-DQN to estimate value functions signaling dead-ends and rescue states.
Datasets and Evaluation
The framework was evaluated on two primary datasets:
- Life-Gate (Toy Problem): A custom grid-world environment where an agent must reach a "life gate" while avoiding "death gates." This proved the algorithm could identify inescapable trajectories before terminal states were reached.
- MIMIC-III (Sepsis Cohort): A real-world dataset containing records for 19,611 septic patients, including 44 clinical variables and 25 discrete treatment choices aggregated into 4-hour windows.
Key Results
The model successfully identified "critical points" where a patient's trajectory shifts toward a dead-end 4 to 8 hours before traditional clinical scores (like SOFA) or clinician interventions show a clear decline.
- Dead-end Confirmation: The model identified that 2.7% of nonsurvivors entered an unavoidable dead-end trajectory up to 48 hours before death, with a remarkably low false-positive rate of 0.2%.
- Detrimental Treatments: Approximately 12% of treatments given to terminally ill patients were flagged as reducing survival chances as early as 24 hours before death.
- The Treatment Gap: Research revealed a significant gap between administered treatments and the "most secure" treatments identified by the model, suggesting some interventions may inadvertently accelerate a path toward a dead-end.
Discussion and Limitations
In safety-critical domains, "avoiding the worst" is often more tractable and useful than "finding the best." Identifying a dead-end is an exponentially smaller problem than learning an optimal global policy. However, limitations remain, including the inherent challenges of offline RL like value overestimation. Future work must address demographic sensitivity and causal ambiguity to definitively prove whether dead-ends are caused by underlying disease or the treatment itself.
Summary updated